ICICI Bank (IBN) Q2 2027 Earnings Call Transcript

ICICI Bank reported Q2 FY2027 profit before tax excluding treasury of INR 199.54 billion, up 23.4% year over year, and standalone profit after tax of INR 148.43 billion, up 20.1%. Deposits grew 27.1% and loans 30%, including USD 18 billion of FCNR (B) deposits; net NPA declined to 0.30% from 0.35% in the prior quarter. Net interest margin fell to 4.18% from 4.36%, with management expecting further moderation in Q3 before recovery from Q4.

Analysis

The key signal is a deliberate trade of near-term spread for funding capacity and franchise growth—not a clean acceleration in underlying profitability. The FCNR-linked expansion adds assets that dilute reported NIM, while related processing fees and deposits help the current-period earnings picture; investors should therefore judge the next two quarters on deployed loan yields, incremental funding cost and core fee growth, not headline loan or fee growth alone. A further Q3 margin dip is already flagged, so the likely near-term risk is disappointment versus expectations for an immediate recovery. The potential offset is that a large share of domestic loans reprices with external benchmarks, while management expects excess liquidity to be deployed over the next two quarters. That benefit depends on earning spreads above the all-in cost of funds and maintaining underwriting discipline.

The less obvious risk is composition: reported loan growth includes overseas lending against FCNR deposits, and corporate/business banking is expanding faster than retail. If that growth proves short-tenor, concentrated or lower-yielding, the balance sheet can expand without comparable returns; corporate lending may also transmit stress indirectly through NBFC/HFC and builder exposures. The strategic upside is durable customer acquisition and transaction-banking income, but it is not yet demonstrated by this quarter’s metrics. For the next 1–3 months, focus on Q3 NIM, deposit mix and evidence of FCNR liquidity deployment; over 6–18 months, test whether core earnings grow after temporary FCNR-related effects fade. The contrarian point: the margin dip may be over-weighted by the market if low-cost funding supports profitable growth, but management’s Q4 recovery is guidance, not proof. Reassess if domestic NIM falls beyond Q3, deployment fails to lift loan yields, or credit costs rise materially from the normalized level cited by management.

Key Decisions for Investors

• Avoid chasing IBN on headline loan growth. Consider a staged long only on weakness, with sizing contingent on Q3 evidence that liquidity is being deployed at attractive spreads; no price target is justified by the information provided.
• For a 1–3 month catalyst, monitor reported NIM alongside domestic NIM, ex-FCNR loan growth, average deposit cost and loan yields. A Q3 decline alone is not thesis-breaking; persistent compression into Q4 would be.
• Treat the fee-growth figure as lower-quality until the company discloses the contribution from FCNR-related processing fees and demonstrates recurring fee momentum. Also separate subsidiary dividend timing from underlying bank earnings.
• Falsification/watch items: FCNR-funded overseas assets remain under-deployed through the next two quarters; Q4 margins fail to recover as guided; credit costs move materially above management’s normalized ~50bp indication; or rising NBFC/HFC and builder stress weakens asset quality.